J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M200249-JLR200 on September 1, 2002

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200249-JLR200v1
43/12/2155    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kummrow, E.
Right arrow Articles by Fisher, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kummrow, E.
Right arrow Articles by Fisher, E. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 43, 2155-2163, December 2002
Copyright © 2002 by Lipid Research, Inc.

Myristic acid increases dense lipoprotein secretion by inhibiting apoB degradation and triglyceride recruitment

Emma Kummrow*, M. Mahmood Hussain*,{dagger}, Meihui Pan§, Julian B. Marsh*,** and Edward A. Fisher1,*,§

* Department of Biochemistry, Medical College of Pennsylvania-Hahnemann School of Medicine, Philadelphia, PA 19129
{dagger} Department of Anatomy and Cell Biology, SUNY Health Science Center, Brooklyn, NY 11203
§ Department of Medicine and The Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029
** Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111

1 To whom correspondence should be addressed. e-mail: edward.fisher{at}mssm.edu

Fatty acids of varying lengths and saturation differentially affect plasma apolipoprotein B-100 (apoB-100) levels. To identify mechanisms at the level of production, rat hepatoma cells, McA-RH7777, were incubated with [35S]methionine and either fatty acid-BSA complexes or BSA alone. There were increases in labeled apoB-100 secretion with saturated fatty acids palmitic and myristic (MA) (153 ± 20% and 165 ± 11%, respectively, relative to BSA). Incubation with polyunsaturated docosahexaenoic acid (DHA) decreased secretion to 26 ± 2.0%, while monounsaturated oleic acid (OA) did not change it. In pulse-chase studies, MA treatment resulted in reduced apoB-100 degradation, in agreement with its promotion of secretion. In triglyceride (TG) studies, synthesis was stimulated equally by OA, MA, and DHA, but TG secretion was relatively decreased with MA and DHA. With OA, the majority of newly secreted apoB100-lipoproteins was d <= 1.006, but with MA, they were much denser (1.063 < d). Furthermore, the relative recruitment of newly synthesized TG to lipoproteins was impaired with MA.

We conclude that mechanisms for effects of specific dietary fatty acids on plasma lipoprotein levels may include changes in hepatic production. In turn, hepatic production may be regulated by specific fatty acids at the steps of apoB-100 degradation and the recruitment of nascent TG to lipoprotein particles.

Abbreviations: DHA, docosahexaenoic acid; MA, myristic acid; OA, oleic acid; PA, palmitic acid; SFA, saturated fatty acid(s); TG, triglyceride(s)

Supplementary key words saturated fatty acid • palmitic acid • oleic acid • polyunsaturated fatty acid • n-3 fatty acid • DHA • VLDL


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
V. Gusarova, J. Seo, M. L. Sullivan, S. C. Watkins, J. L. Brodsky, and E. A. Fisher
Golgi-associated Maturation of Very Low Density Lipoproteins Involves Conformational Changes in Apolipoprotein B, but Is Not Dependent on Apolipoprotein E
J. Biol. Chem., July 6, 2007; 282(27): 19453 - 19462.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Sato, Y. Cho, S. Tachibana, T. Chiba, W. J. Schneider, and Y. Akiba
Impairment of VLDL Secretion by Medium-Chain Fatty Acids in Chicken Primary Hepatocytes Is Affected by the Chain Length
J. Nutr., July 1, 2005; 135(7): 1636 - 1641.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Sjogren, M. Rosell, C. Skoglund-Andersson, S. Zdravkovic, B. Vessby, U. de Faire, A. Hamsten, M.-L. Hellenius, and R. M. Fisher
Milk-Derived Fatty Acids Are Associated with a More Favorable LDL Particle Size Distribution in Healthy Men
J. Nutr., July 1, 2004; 134(7): 1729 - 1735.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
V. Gusarova, J. L. Brodsky, and E. A. Fisher
Apolipoprotein B100 Exit from the Endoplasmic Reticulum (ER) Is COPII-dependent, and Its Lipidation to Very Low Density Lipoprotein Occurs Post-ER
J. Biol. Chem., November 28, 2003; 278(48): 48051 - 48058.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Navab, S. Hama, G. Hough, and A. M. Fogelman
Oral Synthetic Phospholipid (DMPC) Raises High-Density Lipoprotein Cholesterol Levels, Improves High-Density Lipoprotein Function, and Markedly Reduces Atherosclerosis in Apolipoprotein E-Null Mice
Circulation, October 7, 2003; 108(14): 1735 - 1739.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.